Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rubio-San-Simón A
- André N
- Cefalo MG
- Aerts I
- Castañeda A
- Benezech S
- Makin G
- van Eijkelenburg N
- Nysom K
- Marshall L
- Gambart M
- Hladun R
- Rossig C
- Bergamaschi L
- Fagioli F
- Carpenter B
- Ducassou S
- Owens C
- Øra I
- De Wilde B
- Guerra-García P
- Strullu M
- Rizzari C
- Ek T
- Hettmer S
- Gerber NU
- Rawlings C
- Diezi M
- Palmu S
- Ruggiero A
- Verdú J
- de Rojas T
- Vassal G
- Geoerger B
- Moreno L
- Bautista F
Grupos
Abstract
Data regarding real-world impact on cancer clinical research during COVID-19 are scarce. We analysed the impact of the COVID-19 pandemic on the conduct of paediatric cancer phase I-II trials in Europe through the experience of the Innovative Therapies for Children with Cancer (ITCC).
Datos de la publicación
- ISSN/ISSNe:
- 0959-8049, 1879-0852
- Tipo:
- Article
- Páginas:
- 82-91
- PubMed:
- 33129040
- Factor de Impacto:
- 3,354 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
EUROPEAN JOURNAL OF CANCER ELSEVIER SCI LTD
Citas Recibidas en Web of Science: 16
Documentos
- No hay documentos
Filiaciones
Keywords
- COVID-19, Clinical trials, Drug development, Healthcare policy, Paediatric haematology and oncology
Campos de Estudio
Cita
Rubio A,André N,Cefalo MG,Aerts I,Castañeda A,Benezech S,Makin G,van N,Nysom K,Marshall L,Gambart M,Hladun R,Rossig C,Bergamaschi L,Fagioli F,Carpenter B,Ducassou S,Owens C,Øra I,RIBELLES AJ,De Wilde B,Guerra P,Strullu M,Rizzari C,Ek T,Hettmer S,Gerber NU,Rawlings C,Diezi M,Palmu S,Ruggiero A,Verdú J,de Rojas T,Vassal G,Geoerger B,Moreno L,Bautista F. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium. Eur. J. Cancer. 2020. 141. p. 82-91. IF:9,162. (1).
Portal de investigación